Breaking News Instant updates and real-time market news.

2022-12-01 08:13:51 OKTA Okta $53.31 / +2.06 (+4.02%) , MSFT Microsoft $255.13 / +14.78 (+6.15%) 08:13 12/01/22 12/01 08:13 12/01/22 08:13	Okta price target raised to $69 from $58 at BMO Capital BMO Capital analyst Keith Bachman raised the firm's price target on Okta (OKTA) to $69 from $58 and keeps an Outperform rating on the shares after its Q3 earnings beat. Microsoft (MSFT) will continue to serve as an overhang for the stock, but its multiple is still "too low" at present, the analyst tells investors in a research note, adding that Okta management's guidance is also "very conservative". OKTA Okta $53.31 / +2.06 (+4.02%) MSFT Microsoft $255.13 / +14.78 (+6.15%)	13 Dec

2022-12-01 08:13:51

OKTA

Okta

$53.31 / +2.06 (+4.02%)

, MSFT

Microsoft

$255.13 / +14.78 (+6.15%)

08:13

12/01/22

12/01

08:13

12/01/22

08:13

Okta price target raised to $69 from $58 at BMO Capital

BMO Capital analyst Keith Bachman raised the firm's price target on Okta (OKTA) to $69 from $58 and keeps an Outperform rating on the shares after its Q3 earnings beat. Microsoft (MSFT) will continue to serve as an overhang for the stock, but its multiple is still "too low" at present, the analyst tells investors in a research note, adding that Okta management's guidance is also "very conservative".

OKTA

Okta

$53.31 / +2.06 (+4.02%)

MSFT

Microsoft

$255.13 / +14.78 (+6.15%)

13
Dec

OTHER BREAKING NEWS FROM THE FLY

Recommendations	Chipotle price target raised to $2,084 from $1,986 at Citi » 06:18 02/08/23 02/08 06:18 02/08/23 06:18 CMG Chipotle $1,720.98 / +22.435 (+1.32%) Citi analyst Jon Tower… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options CMG Chipotle $1,720.98 / +22.435 (+1.32%) 02/07/23 Chipotle CEO: Feeling very good about where we are right now 02/07/23 Chipotle sees Q1 comparable restaurant sales growth in high-single digits 02/07/23 Chipotle reports Q4 operating margin 13.6%, up from 8.1% last year 01/26/23 Chipotle launches new hiring campaign CMG Chipotle $1,720.98 / +22.435 (+1.32%) 05:27 Today Barclays Chipotle price target raised to $1,550 from $1,450 at Barclays 01/23/23 Wells Fargo Chipotle initiated with an Overweight at Wells Fargo 01/17/23 Morgan Stanley Chipotle downgraded to Equal Weight from Overweight at Morgan Stanley 01/13/23 Evercore ISI Wendy's downgraded to In Line at Evercore, prefers share gainers CMG Chipotle $1,720.98 / +22.435 (+1.32%) 02/07/23 Chipotle reports Q4 adjusted EPS $8.29, consensus $8.90 02/07/23 Notable companies reporting after market close 10/25/22 Chipotle reports Q3 adjusted EPS $9.51, consensus $9.21 10/25/22 Notable companies reporting after market close CMG Chipotle $1,720.98 / +22.435 (+1.32%) 01/12/23 Conagra doesn't see need for 'big' price hikes in 2023, WSJ says 01/11/23 Subway looks into sale that could value company at over $10B, WSJ says 12/30/22 Restaurant coalition sues to stop California fast-food wage law, WSJ says 12/01/22 Twitter offers advertisers big incentives to boost spending, WSJ reports CMG Chipotle $1,720.98 / +22.435 (+1.32%) 02/07/23 Fly Intel: After-Hours Movers 01/24/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/17/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/07/22 #SocialStocks: EU rules against Meta, despite attempts to settle CMG Chipotle $1,720.98 / +22.435 (+1.32%) 02/07/23 Chipotle options imply 5.5% move in share price post-earnings 10/25/22 Chipotle options imply 6.3% move in share price post-earnings
Recommendations	Lululemon price target raised to $400 from $393 at Oppenheimer » 06:17 02/08/23 02/08 06:17 02/08/23 06:17 LULU Lululemon $319.15 / +7.71 (+2.48%) Oppenheimer analyst Brian… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options LULU Lululemon $319.15 / +7.71 (+2.48%) 01/12/23 lululemon teams with Nedap to advance RFID technology across stores 01/09/23 Lululemon falls 14% to $282.02 after revising Q4 guidance 12/08/22 Lululemon falls 9% to $340.75 after Q3 results and guidance 12/08/22 Lululemon reports Q3 SSS up 22% or 25% on constant FX basis LULU Lululemon $319.15 / +7.71 (+2.48%) 01/24/23 Bernstein Lululemon downgraded to Underperform from Market Perform at Bernstein 01/23/23 Jefferies Jefferies store checks find 'flaws' in Lululemon merchandising 01/13/23 Citi Lululemon price target lowered to $350 from $400 at Citi 01/13/23 Barclays Lululemon price target lowered to $394 from $445 at Barclays LULU Lululemon $319.15 / +7.71 (+2.48%) 01/09/23 Lululemon narrows Q4 adjusted EPS view to $4.22-$4.27 from $4.20-$4.30 12/08/22 Lululemon sees FY22 EPS $9.87-$9.97, consensus $9.92 12/08/22 Lululemon sees Q4 EPS $4.20-$4.30, consensus $4.30 12/08/22 Lululemon reports Q3 EPS $2.00, consensus $1.97 LULU Lululemon $319.15 / +7.71 (+2.48%) 09/30/22 Peloton tells Bloomberg resolved dispute with Lululemon over athletic wear 09/29/22 Peloton suit against Lululemon thrown out by court, Bloomberg reports 09/29/22 Lululemon wins dismissal of patent suit by Peloton, Bloomberg reports 08/17/22 Lululemon D.C. workers withdraw bid for union vote, Bloomberg reports LULU Lululemon $319.15 / +7.71 (+2.48%) 01/28/23 Buy/Sell: Wall Street's top 10 stock calls this week 01/24/23 What You Missed On Wall Street On Tuesday 01/24/23 What You Missed On Wall Street This Morning 01/24/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations LULU Lululemon $319.15 / +7.71 (+2.48%) 01/24/23 Unusually active option classes on open January 24th 01/04/23 Lululemon put volume heavy and directionally bearish 12/21/22 Unusually active option classes on open December 21st 12/12/22 Unusually active option classes on open December 12th
Recommendations	Fiserv price target raised to $135 from $122 at Citi » 06:17 02/08/23 02/08 06:17 02/08/23 06:17 FISV Fiserv $115.29 / +8.86 (+8.32%) Citi analyst Ashwin… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options FISV Fiserv $115.29 / +8.86 (+8.32%) 01/19/23 Desjardins selects Fiserv to enhance credit card program 12/21/22 Fiserv enters into new contract with CEO Frank Bisignano FISV Fiserv $115.29 / +8.86 (+8.32%) 05:29 Today Barclays Fiserv price target raised to $140 from $125 at Barclays 01/23/23 Barclays Fiserv price target lowered to $125 from $128 at Barclays 01/09/23 Wells Fargo Fiserv downgraded to Underweight from Equal Weight at Wells Fargo 12/12/22 Mizuho Fiserv price target lowered to $135 from $145 at Mizuho FISV Fiserv $115.29 / +8.86 (+8.32%) 02/07/23 Fiserv sees FY23 adjusted EPS $7.25-$7.40, consensus $7.29 02/07/23 Fiserv reports Q4 adjusted EPS $1.91, consensus $1.90 02/06/23 Notable companies reporting before tomorrow's open 02/06/23 Notable companies reporting before tomorrow's open FISV Fiserv $115.29 / +8.86 (+8.32%) 02/07/23 Fly Intel: Pre-market Movers 10/27/22 Fly Intel: Pre-market Movers 10/12/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/11/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations FISV Fiserv $115.29 / +8.86 (+8.32%) 02/07/23 Early notable gainers among liquid option names on February 7th 12/14/22 Early notable gainers among liquid option names on December 14th 10/10/22 Fiserv call volume above normal and directionally bullish 08/22/22 Fiserv put volume heavy and directionally bearish
Recommendations	Paycom price target raised to $400 from $360 at Oppenheimer » 06:16 02/08/23 02/08 06:16 02/08/23 06:16 PAYC Paycom $344.55 / +14.84 (+4.50%) Oppenheimer analyst Ray… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options PAYC Paycom $344.55 / +14.84 (+4.50%) 08/15/22 Paycom raises share repurchase plan to $1.1B PAYC Paycom $344.55 / +14.84 (+4.50%) 06:13 Today Piper Sandler Paycom price target raised to $417 from $395 at Piper Sandler 01/23/23 Deutsche Bank Paycom price target lowered to $400 from $425 at Deutsche Bank 01/10/23 Barclays Paycom price target lowered to $324 from $347 at Barclays 01/09/23 MoffettNathanson Paycom initiated with an Underperform at MoffettNathanson PAYC Paycom $344.55 / +14.84 (+4.50%) 02/07/23 Paycom sees FY23 revenue $1.7B-$1.702B, consensus $1.69B 02/07/23 Paycom sees Q1 revenue $443M-$445M, consensus $437.11M 02/07/23 Paycom reports Q4 adjusted EPS $1.73, consensus $1.49 02/07/23 Notable companies reporting after market close PAYC Paycom $344.55 / +14.84 (+4.50%) 02/07/23 Fly Intel: After-Hours Movers 01/14/23 Buy/Sell: Wall Street's top 10 stock calls this week 01/09/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 09/01/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/09/23 Paycom PAYC Paycom $344.55 / +14.84 (+4.50%) 10/17/22 Early notable gainers among liquid option names on October 17th
Recommendations	Paycom price target raised to $417 from $395 at Piper Sandler » 06:13 02/08/23 02/08 06:13 02/08/23 06:13 PAYC Paycom $344.55 / +14.84 (+4.50%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options PAYC Paycom $344.55 / +14.84 (+4.50%) 08/15/22 Paycom raises share repurchase plan to $1.1B PAYC Paycom $344.55 / +14.84 (+4.50%) 01/23/23 Deutsche Bank Paycom price target lowered to $400 from $425 at Deutsche Bank 01/10/23 Barclays Paycom price target lowered to $324 from $347 at Barclays 01/09/23 MoffettNathanson Paycom initiated with an Underperform at MoffettNathanson 11/02/22 Cowen Paycom price target raised to $381 from $365 at Cowen PAYC Paycom $344.55 / +14.84 (+4.50%) 02/07/23 Paycom sees FY23 revenue $1.7B-$1.702B, consensus $1.69B 02/07/23 Paycom sees Q1 revenue $443M-$445M, consensus $437.11M 02/07/23 Paycom reports Q4 adjusted EPS $1.73, consensus $1.49 02/07/23 Notable companies reporting after market close PAYC Paycom $344.55 / +14.84 (+4.50%) 02/07/23 Fly Intel: After-Hours Movers 01/14/23 Buy/Sell: Wall Street's top 10 stock calls this week 01/09/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 09/01/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/09/23 Paycom PAYC Paycom $344.55 / +14.84 (+4.50%) 10/17/22 Early notable gainers among liquid option names on October 17th
Earnings	Perion Network sees FY23 revenue $720M-$740M, consensus $730.03M » 06:13 02/08/23 02/08 06:13 02/08/23 06:13 PERI Perion Network $33.53 / -0.21 (-0.62%) Sees FY23 adjusted EBITDA… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options PERI Perion Network $33.53 / -0.21 (-0.62%) 06:09 Today Perion Network announces six-month CEO transition period PERI Perion Network $33.53 / -0.21 (-0.62%) 01/30/23 Needham Perion Network price target raised to $37 from $32 at Needham 01/20/23 Lake Street Lake Street 'comfortable' with revenue growth forecast for Perion Network 02/10/22 Oppenheimer Perion Network price target lowered to $30 from $35 at Oppenheimer PERI Perion Network $33.53 / -0.21 (-0.62%) 06:12 Today Perion Network reports Q4 adjusted EPS 90c, consensus 59c 01/04/23 Perion Network reports preliminary FY22 revenue $636M, consensus $632.26.6M 01/04/23 Perion Network reports preliminary Q4 revenue $205M, consensus $201.6M 11/09/22 Perion Network reports Q3 EPS 61c, consensus 43c PERI Perion Network $33.53 / -0.21 (-0.62%) 01/04/23 What You Missed On Wall Street On Wednesday 01/04/23 What You Missed On Wall Street This Morning 01/04/23 Fly Intel: Pre-market Movers 10/06/22 What You Missed On Wall Street On Thursday 03/12/23 35th Annual Roth Conference 08:30 Today Perion Network - PERI PERI Perion Network $33.53 / -0.21 (-0.62%) 12/09/22 Largest borrow rate increases among liquid names 12/06/22 Largest borrow rate increases among liquid names 11/25/22 Largest borrow rate increases among liquid names
Hot Stocks	The EC transfers marketing authorization for EBVALLO from Atara to Pierre Fabre » 06:12 02/08/23 02/08 06:12 02/08/23 06:12 ATRA Atara Biotherapeutics $5.45 / +0.04 (+0.74%) Pierre Fabre and Atara… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events ATRA Atara Biotherapeutics $5.45 / +0.04 (+0.74%) 12/20/22 Atara announces $31M royalty interest financing pact with HealthCare Royalty 12/19/22 Atara Biotherapeutics chair Ron Renaud to step down, Carol Gallagher to succeed 12/19/22 Atara Biotherapeutics Ebvallo approved by EC for EBV+ PTLD therapy 12/12/22 Atara presents updated clinical data from Phase 3 trial of tab-cel ATRA Atara Biotherapeutics $5.45 / +0.04 (+0.74%) 01/04/23 EF Hutton Atara Biotherapeutics initiated with a Buy at EF Hutton 07/20/22 Citi Atara Biotherapeutics downgraded to Sell from Neutral at Citi 07/13/22 Canaccord Atara Biotherapeutics price target lowered to $50 from $67 at Canaccord 07/13/22 Stifel Stifel downgrades Atara Biotherapeutics to Hold following ATA188 analysis ATRA Atara Biotherapeutics $5.45 / +0.04 (+0.74%) 11/08/22 Atara Biotherapeutics reports Q3 EPS (82c), consensus (78c) 08/08/22 Atara Biotherapeutics reports Q2 EPS 18c, consensus (93c) ATRA Atara Biotherapeutics $5.45 / +0.04 (+0.74%) 08/09/22 What You Missed On Wall Street On Tuesday 08/09/22 What You Missed On Wall Street This Morning 02/16/23 2023 Tandem Meetings of ASTCG and CIBMTR
Recommendations	Carlyle Group price target lowered to $48 from $58 at Piper Sandler » 06:12 02/08/23 02/08 06:12 02/08/23 06:12 CG Carlyle Group $36.42 / +0.135 (+0.37%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly CG Carlyle Group $36.42 / +0.135 (+0.37%) 02/07/23 Carlyle approves increase in common stock dividend to $1.40 annual rate 02/06/23 Carlyle Group names Harvey Schwartz as CEO, board member 02/02/23 Carlyle in talks with ex-Goldman exec Schwartz for CEO role, Semafor says 01/31/23 Jasper Therapeutics discloses Carlyle Group buys $4.7M in common stock CG Carlyle Group $36.42 / +0.135 (+0.37%) 01/31/23 BMO Capital Franklin Resources price target raised to $23 from $22 at BMO Capital 01/02/23 Keefe Bruyette Carlyle Group downgraded to Market Perform from Outperform at Keefe Bruyette 01/02/23 Keefe Bruyette Apollo Global downgraded to Market Perform from Outperform at Keefe Bruyette 12/22/22 Credit Suisse Carlyle's CEO search difficulty well priced in, says Credit Suisse CG Carlyle Group $36.42 / +0.135 (+0.37%) 02/07/23 Carlyle Group reports Q4 distributable EPS $1.01, consensus 96c 11/08/22 Carlyle Group reports Q3 distributable EPS $1.42, consensus $1.06 CG Carlyle Group $36.42 / +0.135 (+0.37%) 02/06/23 Carlyle expected to name ex-Goldman exec as CEO this week, Bloomberg reports 01/13/23 Mason, Pruzan have held talks with Carlyle for CEO role, FT reports 12/22/22 Carlyle Group struggles to find permanent CEO, FT reports 11/30/22 Eni in early talks to acquire Neptune Energy for $5B-$6B, Reuters reports CG Carlyle Group $36.42 / +0.135 (+0.37%) 12/22/22 What You Missed On Wall Street On Thursday 12/22/22 What You Missed On Wall Street This Morning 11/15/22 What You Missed On Wall Street On Tuesday 11/08/22 Fly Intel: Pre-market Movers
Earnings	Perion Network reports Q4 adjusted EPS 90c, consensus 59c » 06:12 02/08/23 02/08 06:12 02/08/23 06:12 PERI Perion Network $33.53 / -0.21 (-0.62%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options PERI Perion Network $33.53 / -0.21 (-0.62%) 06:09 Today Perion Network announces six-month CEO transition period PERI Perion Network $33.53 / -0.21 (-0.62%) 01/30/23 Needham Perion Network price target raised to $37 from $32 at Needham 01/20/23 Lake Street Lake Street 'comfortable' with revenue growth forecast for Perion Network 02/10/22 Oppenheimer Perion Network price target lowered to $30 from $35 at Oppenheimer PERI Perion Network $33.53 / -0.21 (-0.62%) 01/04/23 Perion Network reports preliminary FY22 revenue $636M, consensus $632.26.6M 01/04/23 Perion Network reports preliminary Q4 revenue $205M, consensus $201.6M 11/09/22 Perion Network reports Q3 EPS 61c, consensus 43c 10/06/22 Perion reports preliminary Q3 revenue $158M, consensus $155.4M PERI Perion Network $33.53 / -0.21 (-0.62%) 01/04/23 What You Missed On Wall Street On Wednesday 01/04/23 What You Missed On Wall Street This Morning 01/04/23 Fly Intel: Pre-market Movers 10/06/22 What You Missed On Wall Street On Thursday 03/12/23 35th Annual Roth Conference 08:30 Today Perion Network - PERI PERI Perion Network $33.53 / -0.21 (-0.62%) 12/09/22 Largest borrow rate increases among liquid names 12/06/22 Largest borrow rate increases among liquid names 11/25/22 Largest borrow rate increases among liquid names
Earnings	Edgewell Personal Care sees FY23 adjusted EPS $2.30-$2.50, consensus $2.42 » 06:12 02/08/23 02/08 06:12 02/08/23 06:12 EPC Edgewell Personal Care $42.14 / -0.85 (-1.98%) Raises FY23 revenue view… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events EPC Edgewell Personal Care $42.14 / -0.85 (-1.98%) 12/16/22 Edgewell Personal Care names Robert Schmidt as Chief Accounting Officer 09/15/22 Edgewell Personal Care streamlines leadership and organizational structure EPC Edgewell Personal Care $42.14 / -0.85 (-1.98%) 11/16/22 Canaccord Canaccord starts Edgewell Personal Care at Buy amid men's 'beauty boom' 11/16/22 Canaccord Edgewell Personal Care initiated with a Buy at Canaccord 11/14/22 Barclays Edgewell Personal Care price target raised to $35 from $31 at Barclays 10/25/22 Goldman Sachs Edgewell downgraded to Neutral from Conviction Buy at Goldman Sachs EPC Edgewell Personal Care $42.14 / -0.85 (-1.98%) 06:08 Today Edgewell Personal Care reports Q1 adjusted EPS 31c, consensus 21c 11/10/22 Edgewell Personal Care sees FY23 adjusted EPS $2.30-$2.50, consensus $2.56 11/10/22 Edgewell Personal Care reports Q4 adjusted EPS 79c, consensus 76c 08:00 Today Edgewell Personal Care - EPC

Recommendations	Rockwell Medical price target lowered to $7 from $8 at H.C. Wainwright » 06:11 02/08/23 02/08 06:11 02/08/23 06:11 RMTI Rockwell Medical $1.90 / -0.07 (-3.55%) H.C. Wainwright analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings RMTI Rockwell Medical $1.90 / -0.07 (-3.55%) 02/02/23 Rockwell Medical signs product purchase agreement with dialysis provider 01/09/23 Alimera Sciences appoints Skibsted as Chief Financial Officer, SVP 12/13/22 Rockwell Medical adds hemodialysis business in Minnesota 11/09/22 Rockwell Medical reacquires distribution rights to hemodialysis concentrates RMTI Rockwell Medical $1.90 / -0.07 (-3.55%) 08/30/22 H.C. Wainwright Rockwell Medical price target raised to $8 from $3 at H.C. Wainwright RMTI Rockwell Medical $1.90 / -0.07 (-3.55%) 11/14/22 Rockwell Medical reports Q3 EPS (40c), consensus (48c)
Initiation	Nouveau Monde initiated with a Buy at H.C. Wainwright » 06:11 02/08/23 02/08 06:11 02/08/23 06:11 NMG Nouveau Monde $5.44 / -0.11 (-1.98%) H.C. Wainwright analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals Events NMG Nouveau Monde $5.44 / -0.11 (-1.98%) 11/11/22 Nouveau Monde provides update on Panasonic partnership 10/20/22 Nouveau Monde rises 7.7% 10/20/22 Nouveau Monde, Mitsui and Panasonic enter offtake partnership 08/29/22 Nouveau Monde falls -5.6% NMG Nouveau Monde $5.44 / -0.11 (-1.98%) 10/27/22 B. Riley Nouveau Monde assumed with a Buy at B. Riley NMG Nouveau Monde $5.44 / -0.11 (-1.98%) 09/01/22 Tesla recently visited Nouveau Monde's graphite site in Quebec, Electrek says 03/12/23 35th Annual Roth Conference
Recommendations	Vertex Pharmaceuticals price target raised to $325 from $300 at H.C. Wainwright » 06:09 02/08/23 02/08 06:09 02/08/23 06:09 VRTX Vertex Pharmaceuticals $308.78 / +3.835 (+1.26%) H.C. Wainwright analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options VRTX Vertex Pharmaceuticals $308.78 / +3.835 (+1.26%) 02/07/23 Vertex Pharmaceuticals board authorizes $3.0B buyback 01/11/23 Vertex Pharmaceuticals expands collaboration with Arbor Biotechnologies 12/12/22 FDA clears Vertex IND application for VX-522 to treat CF 12/08/22 Vertex Pharmaceuticals, Entrada Therapeutics enter EEV therapeutics pact VRTX Vertex Pharmaceuticals $308.78 / +3.835 (+1.26%) 05:40 Today Barclays Vertex Pharmaceuticals price target raised to $342 from $313 at Barclays 01/19/23 Piper Sandler Vertex Pharmaceuticals price target raised to $296 from $293 at Piper Sandler 01/18/23 Canaccord Vertex Pharmaceuticals initiated with a Hold at Canaccord 01/17/23 SVB Securities SVB Securities upgrades Vertex to Outperform, raises price target to $374 VRTX Vertex Pharmaceuticals $308.78 / +3.835 (+1.26%) 02/07/23 Vertex Pharmaceuticals guides FY23 revenue $9.55B-$9.70B, consensus $9.6B 02/07/23 Vertex Pharmaceuticals reports Q4 EPS $3.76, consensus $3.51 02/07/23 Notable companies reporting after market close 10/27/22 Vertex Pharmaceuticals raises 2022 revenue to $8.8B-$8.9B from $8.6B-$8.9B VRTX Vertex Pharmaceuticals $308.78 / +3.835 (+1.26%) 02/07/23 Vertex keeps cystic fibrosis drug out of developing countries, NY Times reports VRTX Vertex Pharmaceuticals $308.78 / +3.835 (+1.26%) 12/30/22 What You Missed On Wall Street This Morning 12/19/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 10/31/22 Biotech Alert: Searches spiking for these stocks today 10/27/22 Fly Intel: After-Hours Movers 02/24/23 Vertex Pharmaceuticals VRTX Vertex Pharmaceuticals $308.78 / +3.835 (+1.26%) 02/07/23 Vertex options imply 3.7% move in share price post-earnings 11/28/22 Early notable gainers among liquid option names on November 28th 09/16/22 Early notable gainers among liquid option names on September 16th 09/01/22 Early notable gainers among liquid option names on September 1st
Hot Stocks	Coherent transfer listing to NYSE from Nasdaq » 06:09 02/08/23 02/08 06:09 02/08/23 06:09 COHR Coherent $43.90 / +1.2 (+2.81%) Coherent announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options COHR Coherent $43.90 / +1.2 (+2.81%) 10/18/22 Coherent appoints Julie Sheridan Eng as Chief Technology Officer 10/17/22 Windstream partners with Coherent, Nokia for 400 Gig networking 09/16/22 Coherent introduces ultrahigh-resolution telemetry module 09/15/22 Coherent introduces 200G indium phosphide EMLs for datacenter transceivers COHR Coherent $43.90 / +1.2 (+2.81%) 01/23/23 Barclays Coherent price target raised to $36 from $30 at Barclays 01/17/23 Rosenblatt Coherent initiated with a Buy at Rosenblatt 01/11/23 Craig-Hallum Lumentum price target lowered to $75 from $80 at Craig-Hallum 12/20/22 JPMorgan Coherent price target lowered to $52 from $74 at JPMorgan COHR Coherent $43.90 / +1.2 (+2.81%) 11/09/22 Coherent sees FY23 revenue $5.25B-$5.55B, consensus $5.43B 11/09/22 Coherent sees Q2 adjusted EPS 88c-$1.00, consensus 94c 11/09/22 Coherent reports Q1 adjusted EPS $1.04, consensus 83c COHR Coherent $43.90 / +1.2 (+2.81%) 11/11/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/09/22 What You Missed On Wall Street On Wednesday 11/09/22 What You Missed On Wall Street This Morning 03/07/23 Craig-Hallum Hosted Company Events at OFC 2023 09:00 Today Coherent - COHR 03/08/23 Coherent 03/08/23 Coherent 03/08/23 Coherent COHR Coherent $43.90 / +1.2 (+2.81%) 09/08/22 Four new option listings and two option delistings on September 8th
Upgrade	TripAdvisor upgraded to Buy from Underperform at BofA » 06:09 02/08/23 02/08 06:09 02/08/23 06:09 TRIP TripAdvisor $24.16 / +0.46 (+1.94%) BofA analyst Nat… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options TRIP TripAdvisor $24.16 / +0.46 (+1.94%) 11/30/22 TripAdvisor says Kanika Soni to leave position as Chief Commercial Officer 11/15/22 TripAdvisor names John Boris as Chief Marketing Officer 11/08/22 TripAdvisor: 'Premature' to provide 2023 outlook 11/08/22 TripAdvisor: Travel remains 'robust' TRIP TripAdvisor $24.16 / +0.46 (+1.94%) 12/07/22 Wolfe Research TripAdvisor downgraded to Underperform from Peer Perform at Wolfe Research 11/25/22 DA Davidson TripAdvisor price target lowered to $30 from $33 at DA Davidson 11/09/22 Wells Fargo TripAdvisor price target lowered to $22 from $30 at Wells Fargo 11/09/22 Mizuho TripAdvisor price target lowered to $22 from $26 at Mizuho TRIP TripAdvisor $24.16 / +0.46 (+1.94%) 11/07/22 TripAdvisor sees Q4 revenue of low-single digit increases from 2019 levels 11/07/22 TripAdvisor reports Q3 adjusted EPS 28c, consensus 38c 11/07/22 Notable companies reporting after market close TRIP TripAdvisor $24.16 / +0.46 (+1.94%) 12/10/22 Buy/Sell: Wall Street's top 10 stock calls this week 12/07/22 What You Missed On Wall Street On Wednesday 12/07/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/08/22 What You Missed On Wall Street On Tuesday 02/15/23 TripAdvisor - TRIP TRIP TripAdvisor $24.16 / +0.46 (+1.94%) 12/07/22 TripAdvisor put volume heavy and directionally bearish 11/07/22 TripAdvisor options imply 11.1% move in share price post-earnings
Hot Stocks	Perion Network announces six-month CEO transition period » 06:09 02/08/23 02/08 06:09 02/08/23 06:09 PERI Perion Network $33.53 / -0.21 (-0.62%) Perion Network announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings On The Fly Events Options PERI Perion Network $33.53 / -0.21 (-0.62%) 01/30/23 Needham Perion Network price target raised to $37 from $32 at Needham 01/20/23 Lake Street Lake Street 'comfortable' with revenue growth forecast for Perion Network 02/10/22 Oppenheimer Perion Network price target lowered to $30 from $35 at Oppenheimer PERI Perion Network $33.53 / -0.21 (-0.62%) 01/04/23 Perion Network reports preliminary FY22 revenue $636M, consensus $632.26.6M 01/04/23 Perion Network reports preliminary Q4 revenue $205M, consensus $201.6M 11/09/22 Perion Network reports Q3 EPS 61c, consensus 43c 10/06/22 Perion reports preliminary Q3 revenue $158M, consensus $155.4M PERI Perion Network $33.53 / -0.21 (-0.62%) 01/04/23 What You Missed On Wall Street On Wednesday 01/04/23 What You Missed On Wall Street This Morning 01/04/23 Fly Intel: Pre-market Movers 10/06/22 What You Missed On Wall Street On Thursday 03/12/23 35th Annual Roth Conference 08:30 Today Perion Network - PERI PERI Perion Network $33.53 / -0.21 (-0.62%) 12/09/22 Largest borrow rate increases among liquid names 12/06/22 Largest borrow rate increases among liquid names 11/25/22 Largest borrow rate increases among liquid names
Recommendations	Target price target raised to $220 from $200 at Piper Sandler » 06:08 02/08/23 02/08 06:08 02/08/23 06:08 TGT Target $174.77 / +0.885 (+0.51%) , BBBY Bed Bath & Beyond $3.01 / -2.84 (-48.55%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options TGT BBBY TGT Target $174.77 / +0.885 (+0.51%) 01/31/23 Target says Omaha West store closed until further notice following incident 01/09/23 Mattel's Fisher-Price re-announces recall of 4.7M Rock 'n Play Sleepers 12/22/22 Target recalls roughly 204,000 children's weighted blankets after two deaths 11/25/22 Target announces Cyber Monday sales event from Nov. 27-28 BBBY Bed Bath & Beyond $3.01 / -2.84 (-48.55%) 02/07/23 Bed Bath & Beyond: Default under credit agreement waived 02/07/23 Bed Bath & Beyond has initiated incremental store closures 02/07/23 Bed Bath & Beyond completes public equity offering 02/07/23 Bed Bath & Beyond completes public equity offering, provides strategic update TGT BBBY TGT Target $174.77 / +0.885 (+0.51%) 02/07/23 Barclays Barclays sees a 'reset' in U.S. retail but 'not a recession yet' 02/07/23 Barclays Target initiated with an Equal Weight at Barclays 01/23/23 Oppenheimer Target initiated with an Outperform at Oppenheimer 01/04/23 Wells Fargo Wells Fargo downgrades Target to Equal Weight, lowers price target to $142 BBBY Bed Bath & Beyond $3.01 / -2.84 (-48.55%) 02/07/23 Odeon Capital Bed Bath & Beyond downgraded to Sell from Hold at Odeon Capital 02/07/23 Wedbush Wedbush cuts Bed Bath & Beyond target to 0c amid last effort to avoid bankruptcy 01/11/23 Wedbush Bed Bath & Beyond price target lowered to $1 from $5 at Wedbush 01/11/23 Baird Bed Bath & Beyond price target lowered to $1.00 from $2.00 at Baird TGT BBBY TGT Target $174.77 / +0.885 (+0.51%) 11/16/22 Target on track to deliver total sales of well over $100B this year, says COO 11/16/22 Target reports Q3 adjusted EPS $1.54, consensus $2.13 11/15/22 Notable companies reporting before tomorrow's open 11/15/22 Notable companies reporting before tomorrow's open BBBY Bed Bath & Beyond $3.01 / -2.84 (-48.55%) 01/10/23 Bed Bath & Beyond reports Q3 adjusted EPS ($3.65), consensus ($2.11) 01/05/23 Bed Bath & Beyond sees Q3 net sales of about $1.26B, consensus $1.4B 09/29/22 Bed Bath & Beyond reports Q2 adjusted EPS ($3.22), consensus ($1.85) 09/28/22 Notable companies reporting before tomorrow's open TGT BBBY TGT Target $174.77 / +0.885 (+0.51%) 11/14/22 Walmart taking 'aggressive' stance with suppliers, WSJ reports 10/15/22 Shortages have turned to gluts, off-price retailers could benefit, Barron's says 09/03/22 Target's problems won't last forever, time to buy stock, Barron's says BBBY Bed Bath & Beyond $3.01 / -2.84 (-48.55%) 02/07/23 Hudson Bay anchor investor of Bed Bath share sale, Bloomberg reports 02/02/23 Bed Bath & Beyond misses interest payments, weighs Chapter 11, WSJ reports 01/31/23 Bed Bath & Beyond prepares to seek bankruptcy protection, Reuters reports 01/29/23 Bed Bath & Beyond to close 87 more stores, Harmon chain, WSJ reports TGT BBBY TGT Target $174.77 / +0.885 (+0.51%) 01/28/23 Buy/Sell: Wall Street's top 10 stock calls this week 01/24/23 What You Missed On Wall Street On Tuesday 01/24/23 What You Missed On Wall Street This Morning 01/24/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations BBBY Bed Bath & Beyond $3.01 / -2.84 (-48.55%) 02/07/23 What You Missed On Wall Street On Tuesday 02/07/23 What You Missed On Wall Street This Morning 02/07/23 Fly Intel: Pre-market Movers 02/06/23 Fly Intel: After-Hours Movers TGT BBBY TGT Target $174.77 / +0.885 (+0.51%) 01/19/23 Target put volume heavy and directionally bearish 01/06/23 Early notable gainers among liquid option names on January 6th 01/06/23 Unusually active option classes on open January 6th 11/28/22 Early notable gainers among liquid option names on November 28th BBBY Bed Bath & Beyond $3.01 / -2.84 (-48.55%) 02/07/23 Notable open interest changes for February 7th 02/07/23 Bed Bath & Beyond call buyer realizes 918% same-day gains 02/01/23 Notable open interest changes for February 1st 01/27/23 Notable open interest changes for January 27th
Earnings	Edgewell Personal Care reports Q1 adjusted EPS 31c, consensus 21c » 06:08 02/08/23 02/08 06:08 02/08/23 06:08 EPC Edgewell Personal Care $42.14 / -0.85 (-1.98%) Reports Q1 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events EPC Edgewell Personal Care $42.14 / -0.85 (-1.98%) 12/16/22 Edgewell Personal Care names Robert Schmidt as Chief Accounting Officer 09/15/22 Edgewell Personal Care streamlines leadership and organizational structure EPC Edgewell Personal Care $42.14 / -0.85 (-1.98%) 11/16/22 Canaccord Canaccord starts Edgewell Personal Care at Buy amid men's 'beauty boom' 11/16/22 Canaccord Edgewell Personal Care initiated with a Buy at Canaccord 11/14/22 Barclays Edgewell Personal Care price target raised to $35 from $31 at Barclays 10/25/22 Goldman Sachs Edgewell downgraded to Neutral from Conviction Buy at Goldman Sachs EPC Edgewell Personal Care $42.14 / -0.85 (-1.98%) 11/10/22 Edgewell Personal Care sees FY23 adjusted EPS $2.30-$2.50, consensus $2.56 11/10/22 Edgewell Personal Care reports Q4 adjusted EPS 79c, consensus 76c 08:00 Today Edgewell Personal Care - EPC
Earnings	Ingredion sees FY23 adjusted EPS $7.70-$8.40, consensus $8.22 » 06:08 02/08/23 02/08 06:08 02/08/23 06:08 INGR Ingredion $100.65 / -0.835 (-0.82%) The company expects… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events INGR Ingredion $100.65 / -0.835 (-0.82%) 12/01/22 Ingredion gets SBTi approval of its greenhouse gas emissions reduction targets 11/07/22 Ingredion completes one-third of its $160M in capital investments 09/26/22 Ingredion announces 6M share repurchase plan 09/26/22 Ingredion increases quarterly dividend 9% to 71c per share INGR Ingredion $100.65 / -0.835 (-0.82%) 01/23/23 Barclays Ingredion downgraded to Equal Weight from Overweight at Barclays 01/17/23 Stephens Ingredion upgraded to Overweight from Equal Weight at Stephens 11/07/22 Credit Suisse Ingredion price target raised to $100 from $94 at Credit Suisse 09/30/22 UBS Ingredion initiated with a Neutral at UBS INGR Ingredion $100.65 / -0.835 (-0.82%) 06:06 Today Ingredion reports Q4 adjusted EPS $1.65, consensus $1.45 11/03/22 Ingredion narrows FY22 adjusted EPS view to $7.00-$7.45 from $6.90-$7.45 11/03/22 Ingredion reports Q3 adjusted EPS $1.73, consensus $1.62 08/09/22 Ingredion sees FY22 adjusted EPS $6.90-$7.45, consensus $7.14 INGR Ingredion $100.65 / -0.835 (-0.82%) 01/23/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 09/26/22 Fly Intel: After-Hours Movers 09:00 Today Ingredion - INGR
Upgrade	Royal Caribbean upgraded to Neutral from Underperform at BofA » 06:07 02/08/23 02/08 06:07 02/08/23 06:07 RCL Royal Caribbean $74.05 / +4.96 (+7.18%) BofA analyst Andrew… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options RCL Royal Caribbean $74.05 / +4.96 (+7.18%) 02/07/23 Royal Caribbean jumps 5% to $72.54 after reporting Q4 results, FY23 guidance 02/07/23 Royal Caribbean sees FY23 CapEx $4.1B 02/07/23 Royal Caribbean 'very encouraged about the demand environment for 2023' 01/12/23 Royal Caribbean amends, extends revolving credit facilities RCL Royal Caribbean $74.05 / +4.96 (+7.18%) 05:34 Today Barclays Royal Caribbean price target raised to $88 from $74 at Barclays 04:44 Today Deutsche Bank Royal Caribbean price target raised to $65 from $62 at Deutsche Bank 01/31/23 Citi Royal Caribbean offers most value in cruise sector, says Citi 01/20/23 Deutsche Bank Royal Caribbean price target raised to $62 from $48 at Deutsche Bank RCL Royal Caribbean $74.05 / +4.96 (+7.18%) 02/07/23 Royal Caribbean sees FY23 adjusted EPS $3.00-$3.60, consensus $3.25 02/07/23 Royal Caribbean sees Q1 adjusted EPS (85c)-(65c), consensus (80c) 02/07/23 Royal Caribbean reports Q4 adjusted EPS ($1.12), consensus ($1.34) 11/03/22 Royal Caribbean sees Q4 adjusted EPS ($1.50)-($1.30), consensus (67c) RCL Royal Caribbean $74.05 / +4.96 (+7.18%) 08/17/22 Royal Caribbean seeks approval to sail again in Hong Kong, SCMP reports 08/13/22 Royal Caribbean among companies at risk of liquidity squeeze, Barron's says RCL Royal Caribbean $74.05 / +4.96 (+7.18%) 02/07/23 What You Missed On Wall Street On Tuesday 02/07/23 What You Missed On Wall Street This Morning 01/10/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/10/22 Buy/Sell: Wall Street's top 10 stock calls this week 03/03/23 South Florida Cruise Tour 2023 03/08/23 Bus Tour RCL Royal Caribbean $74.05 / +4.96 (+7.18%) 02/07/23 Early notable gainers among liquid option names on February 7th 02/07/23 Unusually active option classes on open February 7th 01/19/23 Royal Caribbean put volume heavy and directionally bearish 12/21/22 Early notable gainers among liquid option names on December 21st

Earnings	Ingredion reports Q4 adjusted EPS $1.65, consensus $1.45 » 06:06 02/08/23 02/08 06:06 02/08/23 06:06 INGR Ingredion $100.65 / -0.835 (-0.82%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events INGR Ingredion $100.65 / -0.835 (-0.82%) 12/01/22 Ingredion gets SBTi approval of its greenhouse gas emissions reduction targets 11/07/22 Ingredion completes one-third of its $160M in capital investments 09/26/22 Ingredion announces 6M share repurchase plan 09/26/22 Ingredion increases quarterly dividend 9% to 71c per share INGR Ingredion $100.65 / -0.835 (-0.82%) 01/23/23 Barclays Ingredion downgraded to Equal Weight from Overweight at Barclays 01/17/23 Stephens Ingredion upgraded to Overweight from Equal Weight at Stephens 11/07/22 Credit Suisse Ingredion price target raised to $100 from $94 at Credit Suisse 09/30/22 UBS Ingredion initiated with a Neutral at UBS INGR Ingredion $100.65 / -0.835 (-0.82%) 11/03/22 Ingredion narrows FY22 adjusted EPS view to $7.00-$7.45 from $6.90-$7.45 11/03/22 Ingredion reports Q3 adjusted EPS $1.73, consensus $1.62 08/09/22 Ingredion sees FY22 adjusted EPS $6.90-$7.45, consensus $7.14 08/09/22 Ingredion reports Q2 adjusted EPS $2.12, consensus $1.94 INGR Ingredion $100.65 / -0.835 (-0.82%) 01/23/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 09/26/22 Fly Intel: After-Hours Movers 09:00 Today Ingredion - INGR
Hot Stocks	Maxar Technologies awarded $192M contract by the NGA » 06:06 02/08/23 02/08 06:06 02/08/23 06:06 MAXR Maxar Technologies $51.67 / +0.03 (+0.06%) Maxar Technologies… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options MAXR Maxar Technologies $51.67 / +0.03 (+0.06%) 01/04/23 Maxar Technologies announces new contract awards from NGA worth up to $35.8M 12/16/22 Maxar Technologies rises 122.5% 12/16/22 Maxar Technologies rises 119.6% 12/16/22 Maxar Technologies rises 120.5% MAXR Maxar Technologies $51.67 / +0.03 (+0.06%) 12/27/22 Morgan Stanley Morgan Stanley says space-related M&A highlight attractiveness of end market 12/19/22 Northland Maxar deal sheds light on growing value of Planet Labs data, says Northland 12/19/22 TD Securities Maxar Technologies downgraded to Tender from Buy at TD Securities 12/19/22 RBC Capital Maxar Technologies downgraded to Sector Perform from Outperform at RBC Capital MAXR Maxar Technologies $51.67 / +0.03 (+0.06%) 11/03/22 Maxar Technologies reports Q3 EPS (5c), consensus 29c 08/09/22 Maxar Technologies reports Q2 EPS (41c) vs 62c last year MAXR Maxar Technologies $51.67 / +0.03 (+0.06%) 12/19/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/16/22 What You Missed On Wall Street On Friday 12/16/22 Sell these stocks now, proven algorithm says 12/16/22 What You Missed On Wall Street This Morning MAXR Maxar Technologies $51.67 / +0.03 (+0.06%) 12/20/22 Maxar Technologies put volume heavy and directionally bearish
Earnings	CVS Health sees FY24 adjusted EPS $9.00, FY25 adjusted EPS $10.00 » 06:05 02/08/23 02/08 06:05 02/08/23 06:05 CVS CVS Health $86.02 / +0.77 (+0.90%) The company said,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options CVS CVS Health $86.02 / +0.77 (+0.90%) 06:03 Today CVS Health to acquire Oak Street Health for $39 per share 01/26/23 Medavail to sell certain SpotRx pharmacy assets to CVS Health 01/23/23 CVS Health names Bricker CPO, Joyner rejoins as pharmacy services president 01/17/23 Oak Street Health down 7% in afternoon trading CVS CVS Health $86.02 / +0.77 (+0.90%) 02/07/23 Stifel Oak Street Health price target raised to $39 from $35 at Stifel 02/07/23 Piper Sandler Oak Street 'particularly attractive' in current environment, says Piper Sandler 01/31/23 JPMorgan Medicare Advantage final rule more favorable than feared, says JPMorgan 01/27/23 Lake Street Medavail price target lowered to $1 from $4 at Lake Street CVS CVS Health $86.02 / +0.77 (+0.90%) 06:04 Today CVS Health backs FY23 adjusted EPS view $8.70-$8.90, consensus $8.86 02/07/23 Notable companies reporting before tomorrow's open 02/07/23 Notable companies reporting before tomorrow's open 01/10/23 CVS Health reaffirms FY23 adjusted EPS view $8.70-$8.90, consensus $8.86 CVS CVS Health $86.02 / +0.77 (+0.90%) 02/06/23 CVS Health near deal to acquire Oak Street Health for $10.5B, WSJ says 02/06/23 CVS Health near deal to acquire Oak Street Health for $10.5B, WSJ says 01/27/23 Cigna sues CVS Health, Amy Bricker for violating noncompete, Bloomberg Law says 01/19/23 Rite Aid plans to provide abortion pill in some stores, Bloomberg reports CVS CVS Health $86.02 / +0.77 (+0.90%) 02/07/23 What You Missed On Wall Street On Tuesday 02/07/23 What You Missed On Wall Street This Morning 02/07/23 Fly Intel: Pre-market Movers 01/27/23 What You Missed On Wall Street This Morning 02/24/23 Annual Meeting of AAAAI 2023 08:00 Today CVS Health - CVS CVS CVS Health $86.02 / +0.77 (+0.90%) 11/28/22 CVS Health put volume heavy and directionally bearish 11/02/22 Unusually active option classes on open November 2nd 10/19/22 Unusually active option classes on open October 19th 09/13/22 CVS Health call volume above normal and directionally bullish
Earnings	Bunge sees FY23 adjusted EPS 'at least' $11.00, consensus $12.00 » 06:05 02/08/23 02/08 06:05 02/08/23 06:05 BG Bunge $98.92 / -0.64 (-0.64%) In Agribusiness,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events BG Bunge $98.92 / -0.64 (-0.64%) 02/07/23 Bunge increases monitoring of soybeans from indirect supply chain in Brazil 11/22/22 Bunge to acquire 49% stake in BZ Group, terms undisclosed 10/13/22 Bunge, Olleco announce 50/50 edible oils joint venture 10/10/22 Bunge announces over 100 new trainee, internship positions in North America BG Bunge $98.92 / -0.64 (-0.64%) 12/14/22 UBS UBS starts Bunge at Buy on near-term earnings power 12/13/22 UBS Bunge initiated with a Buy at UBS 10/24/22 BofA Green Plains price target lowered to $35 from $43 at BofA 10/24/22 BofA Bunge price target lowered to $130 from $138 at BofA BG Bunge $98.92 / -0.64 (-0.64%) 06:01 Today Bunge reports Q4 adjusted EPS $3.24, consensus $3.22 10/26/22 Bunge raises FY22 adjusted EPS view to at least $13.50 from at least $12.00 10/26/22 Bunge reports Q3 adjusted EPS $3.45, consensus $2.43 BG Bunge $98.92 / -0.64 (-0.64%) 11/30/22 EPA to propose boost in biofuel quotas, Reuters reports 11/30/22 President Biden plans to boost biofuel quotas for next 3 years, Bloomberg says BG Bunge $98.92 / -0.64 (-0.64%) 12/14/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08:00 Today Bunge - BG
Recommendations	Tenable Holdings price target raised to $55 from $50 at Piper Sandler » 06:04 02/08/23 02/08 06:04 02/08/23 06:04 TENB Tenable Holdings $43.41 / +0.965 (+2.27%) Piper Sandler analyst Rob… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly TENB Tenable Holdings $43.41 / +0.965 (+2.27%) 01/26/23 Tenable Holdings announces Tenable Ventures, a corporate investment program 10/31/22 Tenable announces Michelle VonderHaar as chief legal officer, general counsel 10/11/22 Tenable Holdings announces creation of Tenable Research Alliance Program 10/04/22 Tenable Holdings announces release of Tenable One TENB Tenable Holdings $43.41 / +0.965 (+2.27%) 05:36 Today Barclays Tenable Holdings price target raised to $50 from $42 at Barclays 01/24/23 JPMorgan Tenable Holdings initiated with a Neutral at JPMorgan 01/12/23 Morgan Stanley Tenable Holdings downgraded at Morgan Stanley amid near-term security caution 01/12/23 Morgan Stanley Tenable Holdings downgraded to Equal Weight from Overweight at Morgan Stanley TENB Tenable Holdings $43.41 / +0.965 (+2.27%) 02/07/23 Tenable Holdings sees FY23 EPS 52c-56c, consensus 50c 02/07/23 Tenable Holdings sees Q1 EPS 2c-3c, consensus 9c 02/07/23 Tenable Holdings reports Q4 EPS 12c, consensus 7c 10/25/22 Tenable Holdings sees FY22 EPS 32c-33c, consensus 19c TENB Tenable Holdings $43.41 / +0.965 (+2.27%) 02/07/23 Fly Intel: After-Hours Movers 01/24/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 10/25/22 Fly Intel: After-Hours Movers 10/21/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations

Events

Earnings calls, analyst events, roadshows and more

Today at 07:00

MBA Mortgage Applications: Refinance Index W/W: 2/3/2023 Government Event
Today at 07:00

MBA Mortgage Applications: Composite Index W/W: 2/3/2023 Government Event
Today at 07:00

MBA Mortgage Applications: Purchase Index W/W: 2/3/2023 Government Event
EQNR
Today at 07:00

Equinor - EQNR Conference Calls
ITUB
Today at 08:00

Itau Unibanco - ITUB Conference Calls
TRMB
Today at 08:00

Trimble - TRMB Conference Calls
AIZ
Today at 08:00

Assurant - AIZ Conference Calls
CRTO
Today at 08:00

Criteo - CRTO Conference Calls
TEVA
Today at 08:00

Teva - TEVA Conference Calls
CVS
Today at 08:00

CVS Health - CVS Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	BLNK X BLNK Blink Charging Spot Secondary Managers: Barclays Priced at: $12.00 8.333M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	LBPH X LBPH Longboard Pharmaceuticals Spot Secondary Managers: Evercore ISI & Cantor Fitzgerald Priced at: $4.00 5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SINT X SINT Sintx Technologies Spot Secondary Managers: Maxim Priced at: $5.60 2.15M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial STAF X STAF Staffing 360 Solutions Spot Secondary Managers: H.C. Wainwright Priced at: $2.65 1.88M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TMCI X TMCI Treace Medical Spot Secondary Managers: BTIG Priced at: $21.00 4.76M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	CVAC X CVAC CureVac Secondary Managers: Goldman Sachs, Jefferies, SVB Securities & Kempen $10.58 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DT X DT Dynatrace Spot Secondary Managers: BofA $45.55-47.00 15M Shares FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan, Goldman Sachs & Morgan Stanley $139.40-142.25 2M Shares RXST X RXST RxSight Spot Secondary Managers: BofA $12.50-13.00 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial XPOF X XPOF Xponential Fitness Spot Secondary Managers: BofA & Jefferies $24.00-25.00 5M Shares
Wed	BFRG X BFRG Bullfrog AI IPO Managers: WallachBeth, Kingswood $6.50 1.32M Shares HSAI X HSAI Hesai IPO Managers: Goldman Sachs, Morgan Stanley & Credit Suisse, Huatai Securities $17.00 - 19.00 9M Shares INTS X INTS Intensity Therapeutics IPO Managers: Benchmark $4.00-4.50 1.778M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NXT X NXT Nextracker IPO Managers: JPMorgan, BofA, Citi & Barclays, Truist, HSBC, BNP Paribas, Mizuho, Scotiabank, KeyBanc $20.00-23.00 23.26M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	ENLT X ENLT Enlight Renewable Energy IPO Managers: JPMorgan, BofA & Barclays, Credit Suisse, Wolfe Research, Nomura, HSBC, Roth MKM $20.57 14M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LEWY X LEWY LeeWay Services IPO Managers: ThinkEquity $5.00 1M Shares MLYS X MLYS Mineralys Therapeutics IPO Managers: BofA, Ever Bank, Stifel, Credit Suisse, Guggenheim & Wells Fargo $14.00-16.00 10M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Okta price target raised to $69 from $58 at BMO Capital

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access